Reply to: Comments on “Systemic exposure of oxaliplatin and docetaxel in gastric patients with peritonitis carcinomatosis treated with intraperitoneal hyperthermic chemotherapy”

Koemans, W. J.; van Sandick, J. W.; Huitema, A. D.R.

doi:https://doi.org/10.1016/j.ejso.2020.09.019

Reply to: Comments on “Systemic exposure of oxaliplatin and docetaxel in gastric patients with peritonitis carcinomatosis treated with intraperitoneal hyperthermic chemotherapy”

DSpace/Manakin Repository

Reply to: Comments on “Systemic exposure of oxaliplatin and docetaxel in gastric patients with peritonitis carcinomatosis treated with intraperitoneal hyperthermic chemotherapy”

Koemans, W. J.; van Sandick, J. W.; Huitema, A. D.R.

(2020) European Journal of Surgical Oncology, volume 46, issue 12, pp. 2343 - 2343

(Letter)

Download/Full Text

The full text of this publication is not available.

Version on publisher website for UU-students and staff

Version on publisher website

Keywords: Docetaxel, Humans, Hyperthermic Intraperitoneal Chemotherapy, Oxaliplatin/therapeutic use, Peritoneal Neoplasms/drug therapy, Peritonitis/chemically induced, Stomach Neoplasms/drug therapy, Oncology, Surgery, Comment, Letter

DOI: https://doi.org/10.1016/j.ejso.2020.09.019

ISSN: 0748-7983

Publisher: W.B. Saunders Ltd

(Peer reviewed)